- SLRN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-8 Filing
Acelyrin (SLRN) S-8Registration of securities for employees
Filed: 8 May 23, 5:27pm
Exhibit 23.4
Consent of Independent Auditor
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 of Acelyrin, Inc. of our report dated April 29, 2022, except for the presentation of the convertible preferred stock and common stock as described in Note 2 as to which the date is February 10, 2023, with respect to our audit of the financial statements of ValenzaBio, Inc. as of December 31, 2021, and for the year then ended, which appear in ACELYRIN, INC.’s Amendment No. 2 to the Registration Statement on Form S-1 (No. 333-271244).
/s/ Macias Gini & O’Connell LLP
San Jose, California
May 8, 2023
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.